SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS

• 收藏
• 分享

专利权人:

BOEHRINGER INGELHEIM INTERNATIONAL GMBH

发明人:

WIENRICH, MARION,MAYOUX, ERIC

申请号：

CA2837627

公开号：

CA2837627A1

申请日:

2012.05.31

申请国别(地区):

CA

年份:

2012

代理人:

摘要：

The invention relates to methods for preventing, slowing the progression of, delaying or treating metabolic disorders induced in patients by the treatment with neuroleptic agents comprising administering to the patients an SGLT2 inhibitor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/